337 related articles for article (PubMed ID: 32697951)
1. Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy.
Kim AS; Conte MS
Adv Drug Deliv Rev; 2020; 159():170-179. PubMed ID: 32697951
[TBL] [Abstract][Full Text] [Related]
2. Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases.
Satish M; Agrawal DK
Expert Rev Cardiovasc Ther; 2019 Mar; 17(3):177-184. PubMed ID: 30582389
[TBL] [Abstract][Full Text] [Related]
3. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
Serhan CN; Libreros S; Nshimiyimana R
Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
[TBL] [Abstract][Full Text] [Related]
4. Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications.
Wu B; Mottola G; Schaller M; Upchurch GR; Conte MS
Mol Aspects Med; 2017 Dec; 58():72-82. PubMed ID: 28765077
[TBL] [Abstract][Full Text] [Related]
5. Specialized pro-resolving mediators in cardiovascular diseases.
Fredman G; Spite M
Mol Aspects Med; 2017 Dec; 58():65-71. PubMed ID: 28257820
[TBL] [Abstract][Full Text] [Related]
6. Pro-resolution therapeutics for cardiovascular diseases.
Heinz J; Marinello M; Fredman G
Prostaglandins Other Lipid Mediat; 2017 Sep; 132():12-16. PubMed ID: 28450270
[TBL] [Abstract][Full Text] [Related]
7. Specialized pro-resolving lipid mediators in the inflammatory response: An update.
Bannenberg G; Serhan CN
Biochim Biophys Acta; 2010 Dec; 1801(12):1260-73. PubMed ID: 20708099
[TBL] [Abstract][Full Text] [Related]
8. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.
Serhan CN; Chiang N; Dalli J
Semin Immunol; 2015 May; 27(3):200-15. PubMed ID: 25857211
[TBL] [Abstract][Full Text] [Related]
9. Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease.
Spite M; Fredman G
Adv Pharmacol; 2023; 97():257-281. PubMed ID: 37236761
[TBL] [Abstract][Full Text] [Related]
10. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis.
Salazar J; Pirela D; Nava M; Castro A; Angarita L; Parra H; Durán-Agüero S; Rojas-Gómez DM; Galbán N; Añez R; Chacín M; Diaz A; Villasmil N; De Sanctis JB; Bermúdez V
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328553
[TBL] [Abstract][Full Text] [Related]
11. Pro-resolving lipid mediators in vascular disease.
Conte MS; Desai TA; Wu B; Schaller M; Werlin E
J Clin Invest; 2018 Aug; 128(9):3727-3735. PubMed ID: 30168805
[TBL] [Abstract][Full Text] [Related]
12. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation.
Serhan CN; de la Rosa X; Jouvene C
J Intern Med; 2019 Sep; 286(3):240-258. PubMed ID: 30565762
[TBL] [Abstract][Full Text] [Related]
13. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation.
Recchiuti A; Serhan CN
Front Immunol; 2012; 3():298. PubMed ID: 23093949
[TBL] [Abstract][Full Text] [Related]
14. Specialized pro-resolving lipid mediators in endodontics: a narrative review.
Aubeux D; Peters OA; Hosseinpour S; Tessier S; Geoffroy V; Pérez F; Gaudin A
BMC Oral Health; 2021 May; 21(1):276. PubMed ID: 34030680
[TBL] [Abstract][Full Text] [Related]
15. Polyunsaturated fatty acids, specialized pro-resolving mediators, and targeting inflammation resolution in the age of precision nutrition.
Al-Shaer AE; Buddenbaum N; Shaikh SR
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jul; 1866(7):158936. PubMed ID: 33794384
[TBL] [Abstract][Full Text] [Related]
16. Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders.
Han YH; Lee K; Saha A; Han J; Choi H; Noh M; Lee YH; Lee MO
Biomol Ther (Seoul); 2021 Sep; 29(5):455-464. PubMed ID: 34162770
[TBL] [Abstract][Full Text] [Related]
17. Specialized Pro-Resolving Mediators as Resolution Pharmacology for the Control of Pain and Itch.
Ji RR
Annu Rev Pharmacol Toxicol; 2023 Jan; 63():273-293. PubMed ID: 36100219
[TBL] [Abstract][Full Text] [Related]
18. Specialized pro-resolving mediator network: an update on production and actions.
Chiang N; Serhan CN
Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825
[TBL] [Abstract][Full Text] [Related]
19. Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?
Schebb NH; Kühn H; Kahnt AS; Rund KM; O'Donnell VB; Flamand N; Peters-Golden M; Jakobsson PJ; Weylandt KH; Rohwer N; Murphy RC; Geisslinger G; FitzGerald GA; Hanson J; Dahlgren C; Alnouri MW; Offermanns S; Steinhilber D
Front Pharmacol; 2022; 13():838782. PubMed ID: 35308198
[TBL] [Abstract][Full Text] [Related]
20. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors.
Chiang N; Serhan CN
Mol Aspects Med; 2017 Dec; 58():114-129. PubMed ID: 28336292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
